Pediatric Neurology

16
Featured Session · 16 of 35

Pediatric Neurology

Paediatric neurology spans infantile spasms to adolescent neurology with major recent therapeutic advances. The session covers SMA gene therapy real-world (Zolgensma 5-year follow-up), nusinersen and risdiplam comparison data, Duchenne therapeutics (Elevidys gene therapy approval and post-approval surveillance), paediatric epilepsy surgery and the new MR-guided laser ablation (Visualase, NeuroBlate), autism spectrum disorder neurobiology and emerging therapeutics, and adolescent transition to adult care. Discussion addresses tuberous sclerosis complex and mTOR inhibitors, Rett syndrome and trofinetide, neonatal seizure management, paediatric MS and AQP4-NMOSD/MOGAD, and emerging neuromodulation for paediatric epilepsy.

Topics covered in this session
  • Zolgensma 5-year follow-up
  • Elevidys gene therapy
  • Pediatric epilepsy surgery
  • MR-guided laser ablation
  • Trofinetide for Rett syndrome
  • TSC and mTOR inhibitors
  • Pediatric MS/NMOSD/MOGAD
  • Adolescent transition